Celadon Pharmaceuticals

PODCAST: Medical Cannabis – Building a burgeoning sector with Celadon CEO James Short


Here is a great short podcast with Celadon Pharmaceuticals Plc CEO James Short explaining how pharma-grade cannabis-based medicines might help the 8 million adults with untreatable chronic pain in the UK, and why the UK is uniquely placed to build a burgeoning industry.
Fresh off becoming the only AIM-listed cannabinoid company in the UK, Celadon is working tirelessly to improve the quality of life for millions across the UK with chronic pain.

Click here to listen to the full podcast.